Argentina

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 22:37, July 15, 2019 by Kmdenmark (talk | contribs) (removed See also link that doesn't related to page)
Argentina

-brief description-

Medical guidelines

National health department

Government health insurance

Private health insurance

Access to care

Ampligen has been approved for use by the Argentine Republic for severe ME/CFS as of August 23, 2016.[1]

Social security and disability benefits

Patient charities

Research

Research groups

Researchers

Clinicians

Notable patients

Deceased patients

Learn more

See also

References

  1. Inc., Hemispherx Biopharma, (August 23, 2016). "Hemispherx Biopharma Announces Major Breakthrough: Approval for Commercial Sale of Rintatolimod (U.S. Tradename: Ampligen®) to Treat Severe Cases of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in the Argentine Republic". GlobeNewswire News Room. Retrieved August 12, 2018. Cite has empty unknown parameter: |dead-url= (help)CS1 maint: extra punctuation (link)